Applied DNA Sciences Inc

자세한 내용은 Applied DNA Sciences Inc 회사

Applied DNA Sciences, Inc. is a biotechnology company. The Company is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Company operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.

회사 정보

종목 코드 APDN

회사 이름Applied DNA Sciences Inc

상장일Aug 24, 2001

CEOMs. Judith Murrah

직원 수46

유형Ordinary Share

회계 연도 종료Aug 24

주소50 Health Sciences Drive

도시STONY BROOK

증권 거래소NASDAQ Capital Market Consolidated

국가United States of America

우편 번호11790

전화16312408800

웹사이트https://adnas.com/

종목 코드 APDN

상장일Aug 24, 2001

CEOMs. Judith Murrah

회사 임원

이름

이름/직위

직위

주식 보유

변동

Mr. Clay Shorrock, J.D.

President of LRx

4.00

--

Ms. Beth M. Jantzen

Chief Financial Officer

3.00

--

Ms. Judith Murrah

Chairman of the Board, President, Chief Executive Officer

3.00

--

Mr. Robert B. (Bob) Catell

Independent Director

2.00

--

Dr. Yacov A. Shamash, Ph.D.

Independent Director

2.00

--

Mr. Joseph D. Ceccoli

Independent Director

1.00

--

Ms. Elizabeth M. Schmalz Shaheen

Independent Director

--

Dr. Sanford R. Simon, Ph.D.

Independent Director

--

Mr. Sanjay M. Hurry

Executive Director - Investor Relations and Corporate Communications

--

이름

이름/직위

직위

주식 보유

변동

Mr. Clay Shorrock, J.D.

President of LRx

4.00

--

Ms. Beth M. Jantzen

Chief Financial Officer

3.00

--

Ms. Judith Murrah

Chairman of the Board, President, Chief Executive Officer

3.00

--

Mr. Robert B. (Bob) Catell

Independent Director

2.00

--

Dr. Yacov A. Shamash, Ph.D.

Independent Director

2.00

--

Mr. Joseph D. Ceccoli

Independent Director

1.00

--

수익 분석

통화: USD마지막 업데이트: Sun, Jul 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2021

FY2020

FY2019

사업별USD

이름

수익

비율

Product and authentication services - Large scale DNA production

333.66K

33.93%

Product and authentication services - Supply chain

290.23K

29.51%

Clinical laboratory testing services (over-time)

220.55K

22.43%

Research and development services

133.55K

13.58%

Product and authentication services - Asset marking

5.38K

0.55%

데이터 없음

사업별

지역별

사업별USD

이름

수익

비율

Product and authentication services - Large scale DNA production

333.66K

33.93%

Product and authentication services - Supply chain

290.23K

29.51%

Clinical laboratory testing services (over-time)

220.55K

22.43%

Research and development services

133.55K

13.58%

Product and authentication services - Asset marking

5.38K

0.55%

주식 보유 통계

마지막 업데이트: Sat, Jul 19

주주

주주 유형

주주

비율

Sabby Management, LLC

1.34%

Altium Capital Management LP

1.25%

S.H.N. Financial Investments Ltd

0.97%

Bigger (Michael)

0.96%

Anson Funds Management LP.

0.88%

Other

94.60%

주주

비율

Sabby Management, LLC

1.34%

Altium Capital Management LP

1.25%

S.H.N. Financial Investments Ltd

0.97%

Bigger (Michael)

0.96%

Anson Funds Management LP.

0.88%

Other

94.60%

주주 유형

주주

비율

Investment Advisor/Hedge Fund

2.59%

Corporation

1.77%

Individual Investor

0.99%

Hedge Fund

0.89%

Investment Advisor

0.45%

Research Firm

0.03%

Other

93.28%

기관 주식 보유

마지막 업데이트: Tue, Jul 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q2

62

34.90K

6.72%

-9.01K

2025Q1

84

45.20K

34.86%

+11.50K

2024Q4

79

25.60M

46.39%

+1.44M

2024Q3

74

1.08M

9.78%

+703.30K

2024Q2

73

1.19M

10.83%

+424.27K

2024Q1

67

243.32K

209.10%

+86.27K

2023Q4

64

96.98K

13.46%

-84.74K

2023Q3

66

149.12K

21.28%

-82.31K

2023Q2

68

142.47K

21.43%

-74.27K

2023Q1

68

128.77K

20.06%

-84.88K

주주 활동

이름

보유 주식

비율

변동

Chg %

날짜

Sabby Management, LLC

6.97K

1.34%

+1.29K

+22.64%

Dec 31, 2024

Altium Capital Management LP

6.50K

1.25%

--

Apr 03, 2025

S.H.N. Financial Investments Ltd

5.03K

0.97%

--

Apr 03, 2025

Bigger (Michael)

5.00K

0.96%

--

Apr 03, 2025

Anson Funds Management LP.

4.57K

0.88%

-9.44K

-67.39%

Apr 03, 2025

L1 Capital Global Opportunities Master Fund Ltd.

4.17K

0.8%

--

Apr 03, 2025

UBS Financial Services, Inc.

2.31K

0.44%

+2.31K

--

Mar 31, 2025

Grossman (Bruce)

111.00

0.02%

+111.00

--

Feb 02, 2024

Barclays Capital Inc.

80.00

0.02%

+80.00

--

Mar 31, 2025

SBI Securities Co., Ltd.

67.00

0.01%

-90.00

-57.32%

Mar 31, 2025

4.295USD

Applied DNA Sciences Inc

4.295

개요

회사

금융